Description

Cannabis Lending After Rescheduling: What Changes, What Matters, What’s Next

With medical cannabis rescheduling now a reality, the conversation is shifting from policy to practical impact, especially for financial institutions with lending exposure or interest in entering the space. This webinar will feature a timely discussion with cannabis tax and risk experts as they break down what this moment means for bankers. In particular, we will discuss how changes tied to the Section 280E tax code may impact operator cash flow, credit profiles, and overall lending risk. Panelists will explore why medical cannabis businesses may present a different risk profile going forward, what lenders should be watching for in both medical and adult-use operators, and how to assess borrowers in a rapidly evolving environment.

Topics will include:

  • What rescheduling means for 280E and near-term tax implications
  • How shifting tax treatment could impact operator cash flow and debt service capacity
  • Key credit risk considerations for cannabis lending programs
  • Red flags and underwriting considerations across medical vs. adult-use operators
  • Questions bankers should be asking now—before extending or expanding credit


Designed specifically for financial institutions serving or considering serving licensed cannabis businesses, this webinar will deliver practical, actionable insights to help you evaluate risk, identify opportunity, and make more informed lending decisions.

Webinar Details

Wednesday, May 20, 2026
3:00 pm - 4:00 pm ET

Instructor(s)

Jill Scher

Managing Director, Tax and Business Services - CBIZ

Jill Scher, Managing Director, Tax & Business Services Division, CBIZ

Scott Moskol

Blank Rome - Partner

Scott Moskol is a partner and co-chair of the firm’s cannabis practice, and a member of the corporate practice. Scott has developed a national platform representing and counseling clients with respect to all legal issues that may arise in restructurings, workouts, bankruptcies, receiverships, and other insolvency-related matters including distressed mergers and acquisitions (“M&A”).

Tony Repanich

President & CEO - Shield Compliance

Tony Repanich is the President and Chief Executive Officer of Shield Compliance, where he leads the company’s strategic direction and serves as the principal architect of its compliance solutions. With over 30 years of experience in the financial services industry, including two decades as a senior executive at a Washington State-based community bank, Tony brings deep expertise in banking operations, regulatory compliance, and risk management. At Shield Compliance, he leverages this experience to help financial institutions navigate the complex regulatory landscape of serving high-risk industries, including the legal cannabis industry. His leadership drives the development of purpose-built solutions that enable banks to manage risk, streamline operations, and expand into high-growth markets.

About Shield Compliance

Shield Compliance transforms how financial institutions serve the legal cannabis market. Its purpose-built BSA/AML compliance management software solution sits behind the financial institution to simplify compliance, automate processes across multiple data sources, create efficiencies, unlock new revenue, and scale operations. With real-time monitoring and comprehensive reporting capabilities, Shield Compliance sets the standard for compliance excellence in cannabis banking.